Faecal inflammatory markers in nutrition and digestive diseases in children;Marqueurs inflammatoires fécaux en nutrition et pathologies digestives chez l'enfant

Archives de Pediatrie

Volumn 11, Issue 5, 2004, Pages 403-405

  Kapel, N ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alpha 1 antitrypsine; Alpha 1 antitrypsin; Biological markers; Calprotectin; Calprotectine; Child; Inflammatory bowel diseases; Maladies inflammatoires chroniques de l'intestin (MICI); Marqueurs inflammatoires f caux; TNF alpha

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CALPROTECTIN; LACTOFERRIN; TUMOR NECROSIS FACTOR ALPHA;

CHILD; CHILD HEALTH; DIGESTIVE SYSTEM INFLAMMATION; EDITORIAL; ENTERITIS; ENZYME ANALYSIS; GASTROINTESTINAL DISEASE; HUMAN; IMMUNODIFFUSION; INFLAMMATION; NUTRITION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 2342663175     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2004.02.015     Document Type: Article

References (19)

1. Florent C., L'Hirondel C., Desmazures C., Aymes C., Bernier J.J. Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology. 81:1981;777-780
2. Keller K.M., Knobel R., Ewe K. Fecal alpha 1-antitrypsin in newborn infants. J Pediatr Gastroenterol Nutr. 24:1997;271-275
3. Perlmutter D.H., Daniels J.D., Auerbach H.S., De Schryver-Kecskemeti K., Winter H.S., Alpers D.H. The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J Biol Chem. 264:1989;9485-9490
4. Lisowska-Myjak B., Pachecka J., Sokrates O., Brzozowska-Binda A., Torbicka E. Fecal alpha-1-antitrypsin excretion in children with diarrhea. Scand J Gastroenterol. 33:1998;255-259
5. Guerrant R.L., Araujo V., Soares E., Kotloff K., Lima A.A., Cooper W.H., et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol. 30:1992;1238-1242
6. Sugi K., Saitoh O., Hirata I., Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol. 91:1996;927-934
7. Saitoh O., Kojima K., Sugi K., Matsuse R., Uchida K., Tabata K., et al. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am J Gastroenterol. 94:1999;3513-3520
8. Braegger C.P., Nicholls S., Murch S.H., Stephens S., MacDonald T.T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet. 339:1992;89-91
9. Soulé J.C., Andant C., Kapel N., Gobert J.G. Evaluation of fecal tumor necrosis factor alpha (TNFα) as a marker of Crohn's disease (CD) activity. Gastroenterology. 114:1998;A1089
10. Tibble J.A., Sigthorsson G., Foster R., Forgacs I., Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology. 123:2002;450-460
11. Olafsdottir E., Aksnes L., Fluge G., Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr. 91:2002;45-50
12. Carroccio A., Iacono G., Cottone M., Di Prima L., Cartabellotta F., Cavataio F., et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem. 49:2003;861-867
13. Fagerhol M.K. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet. 356:2000;1783-1784
14. Isaksen B., Fagerhol M.K. Calprotectin inhibits matrix metalloproteinases by sequestration of zinc. Mol Pathol. 54:2001;289-292
15. Tibble J., Teahon K., Thjodleifsson B., Roseth A., Sigthorsson G., Bridger S., et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 47:2000;506-513
16. Fagerberg U.L., Loof L., Merzoug R.D., Hansson L.O., Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr. 37:2003;468-472
17. Rugtveit J., Fagerhol M.K. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr. 34:2002;323-324
18. Campeotto F., Butel M.J., Kalach N., Derrieux S., Aubert-Jacquin C., Barbot L., et al. High faecal calprotectin levels in newborns. Arch Dis Child Fetal Neonatal Ed. 2004;. (sous presse)
19. Carroll D., Corfield A., Spicer R., Cairns P. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet. 361:2003;310-311